Evidence map›Paper›PMID 36190080›Full record

ArticleIndian journal of ophthalmology2022

Retinal venous occlusion in a child following Corbevax COVID-19 vaccination.

Purna Nangia, V Jaya Prakash, Parthopratim Dutta Majumder

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Indian journal of ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Purna NangiaDepartment of Vitreoretina, Medical Research Foundations, Sankara Nethralaya, Sankara Nethralaya, Chennai, Tamil Nadu, India.
V Jaya PrakashDepartment of Vitreoretina, Medical Research Foundations, Sankara Nethralaya, Sankara Nethralaya, Chennai, Tamil Nadu, India.
Parthopratim Dutta MajumderUvea, Medical Research Foundations, Sankara Nethralaya, Sankara Nethralaya, Chennai, Tamil Nadu, India.
Sankara Nethralaya · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 13-year-old boy developed painless diminution of vision in left eye 15 days after taking first dose of coronavirus disease 2019 (COVID-19) vaccine (Corbevax). Fundus and fluorescein angiography revealed central retinal vein occlusion in the left eye. Blood investigations were noncontributory. He was administered three doses of pulse corticosteroids followed by a tapering dose of oral corticosteroids. Retinal vascular occlusion can occur following COVID-19 vaccination in children, and early and aggressive systemic anti-inflammatory therapy can be helpful.

Indexed as

COVID-19COVID-19 VaccinesRetinal Vein OcclusionAdolescentAnti-Inflammatory AgentsChildFluorescein AngiographyHumansMaleVaccinationAnti-Inflammatory AgentsCOVID-19 VaccinesCorbevax vaccineCOVID-19retinal vein occlusionvascular occlusion

Identifiers

PMID36190080
PMCPMC9789814
OpenAlexW4300689989

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.